I

InBody Co Ltd
KOSDAQ:041830

Watchlist Manager
InBody Co Ltd
KOSDAQ:041830
Watchlist
Price: 29 100 KRW -1.85%
Market Cap: ₩392.3B

InBody Co Ltd
Total Receivables

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

InBody Co Ltd
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
I
InBody Co Ltd
KOSDAQ:041830
Total Receivables
₩32.5B
CAGR 3-Years
21%
CAGR 5-Years
30%
CAGR 10-Years
11%
I
I Sens Inc
KOSDAQ:099190
Total Receivables
₩71.4B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
11%
C
Classys Inc
KOSDAQ:214150
Total Receivables
₩51.6B
CAGR 3-Years
83%
CAGR 5-Years
71%
CAGR 10-Years
93%
W
Won Tech Co Ltd
KOSDAQ:336570
Total Receivables
₩20B
CAGR 3-Years
901%
CAGR 5-Years
482%
CAGR 10-Years
N/A
V
Viol Co Ltd
KOSDAQ:335890
Total Receivables
₩7.5B
CAGR 3-Years
40%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Seers Technology Co Ltd
KOSDAQ:458870
Total Receivables
₩4.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

InBody Co Ltd
Glance View

Market Cap
392.3B KRW
Industry
Health Care

InBody Co., Ltd. engages in the manufacture and sale of medical equipment. The company is headquartered in Seoul, Seoul. The company went IPO on 2000-12-14. The firm mainly produces body composition analyzers under the brand names of InBody and Lookin’Body. The firm mainly produces body composition analyzers under the brand name InBody and Lookin’Body. Its InBody series products include InBody720, InBody520, InBody230, InBody R20, InBody S20, InBody S10 and InBody J10. Its Lookin' series products include Lookin’Body3.0 and Lookin’Body Basic, which are used for measuring proteins, minerals, fats, moistures and others. The company also provides body mass index (BMI) measuring devices under the brand name of BSM. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
36 034.47 KRW
Undervaluation 19%
Intrinsic Value
Price ₩29 100
I

See Also

What is InBody Co Ltd's Total Receivables?
Total Receivables
32.5B KRW

Based on the financial report for Dec 31, 2025, InBody Co Ltd's Total Receivables amounts to 32.5B KRW.

What is InBody Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 10Y
11%

Over the last year, the Total Receivables growth was 29%. The average annual Total Receivables growth rates for InBody Co Ltd have been 21% over the past three years , 30% over the past five years , and 11% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett